 OSLO, Norway--BUSINESS WIRE--- ULTI ASCO--Ultimovacs ASA Ultimovacs OSE ULTI, a clinical stage leader in immune stimulatory vaccines for cancer, today announced that its management team will discuss data from the abstract of a poster presentation at the American Society of Clinical Oncology ASCO 2021 Annual Meeting at a series of investor events in May, beginning with a live corporate webcast on Thursday May 20, 2021. The abstract is titled A Phase I Clinical Trial Investigating the Telomerase Va 